Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
A microbiological analysis of 102 patients suffering from cystic fibrosis was conducted over a 22 month period. 20 microbial species with the following incidence were identified: Pseudomonas aeruginosa: 83.4%; Candida albicans: 29.4%; Staphylococcus aureus: 24.5%; Staphylococcus epidermidis: 11.8%; Haemophilus influenzae: 11.8%; Streptococcus pneumoniae; 6.9%; Pseudomonas maltophilia: 6.8%; Aspergillus fumigatus: 5.9%. Other species were present in less than 5% of the patients. In the majority of specimens with P. aeruginosa, more than one type (up to six) was detectable. These strains were identical in colony appearance, O-serotype and pyocin-type. Quantitative analysis revealed concentrations of colony-forming units of 10(7) to 10(9) for P. aeruginosa, 10(6) to 10(8) for P. maltophilia, 10(4) to 10(7) for S. aureus, 10(4) to 10(6) for S. epidermidis and 10(4) to 10(7) for C. albicans in the majority of specimens. Significant differences were observed in the time periods during which the pathogens persisted in the patients. Maximum persistence was observed for P. aeruginosa. P. maltophilia and A. fumigatus had about similar persistence rates, which were lower than those for P. aeruginosa but above those for S. aureus and H. influenzae. S. epidermidis was eliminated within shorter periods than S. aureus. C. albicans, although the second most frequent microorganism identified, showed a very low persistence rate. The microbiological analysis confirms results from other research centers (high incidence of P. aeruginosa), but reveals significant regional differences as well (Pseudomonas cepacia not detectable, higher incidence of P. maltophilia and C. albicans). This underlines the necessity for detailed qualitative and quantitative microbiological analysis of sputa from cystic fibrosis patients as a prerequisite for rational analysis of etiological, epidemiological and therapeutical aspects of cystic fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An example of this is the acidification of an environment through acid production (such as lactate) by bacteria such as Staphylococcus aureus, a frequent co-isolate with C. albicans from patients' lungs with cystic fibrosis (CF) as well as Streptococci (Bauernfeind et al., 1987; Friedman et al., 2006; Chotirmall et al., 2010).”
From Iron at the Centre of Candida albicans Interactions (2018) · cites this paper as Bauernfeind et al., 1987
Citations
Cites
Manual of Clinical Microbiology
Blair, J. E., Lennette, E. H., & Truant, J. P. (1970) · Postgraduate Medical Journal · doi:10.1136/pgmj.46.542.733-c · Cited by 2,642
Identification of Enterobacteriaceae.
Edwards, P. R., & Ewing, W. H. (1972) · Andalas University Repository (Andalas University) · Cited by 2,038
Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
Isles, A., Maclusky, I., Corey, M., Gold, R., Prober, C., Fleming, P., & Levison, H. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80993-2 · Cited by 846
Allergic bronchopulmonary aspergillosis in cystic fibrosis
Laufer, P., Fink, J. N., Bruns, W. T., Unger, G. F., Kalbfleisch, J. H., Greenberger, P. A., & Patterson, R. (1984) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(84)90482-2 · Cited by 278
Identification of enterobacteriaceae
Balows, A. (1987) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(87)90124-6 · Cited by 243
MICROBIOLOGY OF LUNG INFECTIONS IN CYSTIC FIBROSIS PATIENTS
HØIBY, N. (1982) · Acta Paediatrica · doi:10.1111/j.1651-2227.1982.tb09640.x · Cited by 226
Aspergillosis and atopy in cystic fibrosis.
Nelson, L. A., Callerame, M., & Schwartz, R. H. (1979) · PubMed · doi:10.1164/arrd.1979.120.4.863 · Cited by 205
A simple test system for the separation of staphylococci from micrococci
Schleifer, K. H., & Kloos, W. E. (1975) · Journal of Clinical Microbiology · doi:10.1128/jcm.1.3.337-338.1975 · Cited by 176
Pseudomonas aeruginosa : clinical manifestations of infection and current therapy
Doggett, R. G., & Aduan, R. P. (1979) · Academic Press eBooks · Cited by 157
Forstner, G. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90777-2 · Cited by 147
Research works printed but not linked: 1
- Govan, J. B. Pseudomonas aeruginosa and respiratory infection in cystic fibrosis. Cystic Fibrosis News. Focus on Research: Number 48 (1983) 5–9.
Cited by
Frey-Klett, P., Burlinson, P., Deveau, A., Barret, M., Tarkka, M., & Sarniguet, A. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00020-11 · Cited by 913
“Complexes containing bacteria and fungi are found in many distinct environments, such as the lungs of cystic fibrosis patients (31); the human oral cavity (16); the production of foods such as cheese, wine, tempeh, and sourdough (408); and agricultural and forest environments (119, 402).”
BackgroundWhy chronic wounds will not heal: a novel hypothesis
Bjarnsholt, T., Kirketerp‐Møller, K., Jensen, P. Ø., Madsen, K. G., Phipps, R., Krogfelt, K., Høiby, N., & Givskov, M. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00283.x · Cited by 886
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
Denton, M., & Kerr, K. G. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.1.57 · Cited by 852
The Changing Microbial Epidemiology in Cystic Fibrosis
LiPuma, J. J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00068-09 · Cited by 806
Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients
Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., Pressler, T., Givskov, M., & Høiby, N. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.21011 · Cited by 795
Medically important bacterial-fungal interactions
Peleg, A. Y., Hogan, D. A., & Mylonakis, E. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2313 · Cited by 619
“Furthermore, colonization of the respiratory tract by bacteria and fungi is especially frequent in patients with chronic lung disease”
BackgroundMicrobiology of airway disease in patients with cystic fibrosis
Gilligan, P. H. (1991) · Clinical Microbiology Reviews · doi:10.1128/cmr.4.1.35 · Cited by 529
Bjarnsholt, T., Jensen, P. Ø., Burmølle, M., Hentzer, M., Haagensen, J. A. J., Hougen, H. P., Calum, H., Madsen, K. G., Moser, C., Molin, S., et al. (2005) · Microbiology · doi:10.1099/mic.0.27463-0 · Cited by 500
“The progressive development of the lung disease is the main cause of morbidity and mortality in CF patients (Davis et al., 1996), and up to 80 % of young adults suffering from CF are chronically infected with P. aeruginosa (Koch & Hoiby, 2000; Gilligan, 1991; Bauernfeind et al., 1987).”
BackgroundKahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357
Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa
Cugini, C., Calfee, M. W., Farrow, J. M., Morales, D. K., Pesci, E. C., & Hogan, D. A. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05840.x · Cited by 332
Pihet, M., Carrere, J., Cimon, B., Chabasse, D., Delhaes, L., Symoens, F., Bouchara, J.-P., Pihet, M., Carrere, J., Cimon, B., et al. (2009) · Medical Mycology · doi:10.1080/13693780802609604 · Cited by 303
“Nelson et al. [6] USA (46) 21/37 (56.7) 5 (10.8) Laufer et al. [7] USA (100) 5/55 (9) 10 (10) Bauernfeind et al. [ 8 ] Germany (102) 6 (5.9) Not specified Simmonds et al. [9] UK (137) Not specified 8 (5.8) Marchant et al. [10] UK (160) Not specified 11 (6.8) Mroueh and Spock [11] USA (236) 60 (25.4) 15 (6.4) Becker et…”
InfluentialBamford, C. V., d'Mello, A., Nobbs, A. H., Dutton, L. C., Vickerman, M. M., & Jenkinson, H. F. (2009) · Infection and Immunity · doi:10.1128/iai.00438-09 · Cited by 291
“albicans may be coisolated with Staphylococcus (67) and with Pseudomonas aeruginosa from other body sites (6, 47).”
The Role of Inflammation in the Pathophysiology of CF Lung Disease
Chmiel, J. F., Berger, M., & Konstan, M. W. (2002) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:23:1:005 · Cited by 255
Chmiel, J. F., & Davis, P. B. (2003) · Respiratory Research · doi:10.1186/1465-9921-4-8 · Cited by 254
“In CF, chronic endobronchial bacterial infections display a limited spectrum of organisms including H. influenzae, S. aureus, P. aeruginosa, B. cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans [ 39 ,40].”
Interkingdom metabolic transformations captured by microbial imaging mass spectrometry
Moree, W. J., Phelan, V. V., Wu, C.-H., Bandeira, N., Cornett, D. S., Duggan, B. M., & Dorrestein, P. C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206855109 · Cited by 239
“Phenazine-1-carboxamide (PCN; 13) and PCA (3) were both so profusely secreted by P.”
BackgroundMethodInfluentialHöfs, S., Mogavero, S., & Hube, B. (2016) · Journal of Microbiology · doi:10.1007/s12275-016-5514-0 · Cited by 238
“…exists between C. albicans and the opportunistic bacterial pathogen Pseudomonas aeruginosa, which can be found in mixed infections in the case of contaminated catheters or chronic lung infections (Hughes and Kim, 1973; Bauernfeind et al., 1987; Hermann et al., 1999; Macedo and Santos, 2005).”
BackgroundRybtke, M., Hultqvist, L. D., Givskov, M., & Tolker-Nielsen, T. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.08.016 · Cited by 227
The innate immune system in cystic fibrosis lung disease
Bals, R., Weiner, D. J., & Wilson, J. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6277 · Cited by 213
Wiesemann, H. G., Steinkamp, G., Ratjen, F., Bauernfeind, A., Przyklenk, B., Döring, G., & von der Hardt, H. (1998) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199802)25:2<88::aid-ppul3>3.0.co;2-j · Cited by 200
Self-citationGibson, J., Sood, A., & Hogan, D. A. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01037-08 · Cited by 195
“Numerous reports indicate that P. aeruginosa and Candida albicans can coexist in a variety of different opportunistic infections ( 1 , 10, 16, 36), and a number of different molecular interactions between these two organisms have been described (18, 19, 23, 24).”
BackgroundGastroesophageal reflux in infants with wheezing
Sheikh, S. I., Stephen, T., Howell, L., & Eid, N. S. (1999) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199909)28:3<175::aid-ppul3>3.0.co;2-u · Cited by 92
Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens
Bjarnsholt, T., & Givskov, M. (2007) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2007.2046 · Cited by 187
“Up to 80% of young adults suffering from CF are chronically infected with P. aeruginosa (Bauernfeind et al. 1987; Gilligan 1991; Koch & Hoiby 2000; Collier et al. 2002; Koch 2002).”
BackgroundBakare, N., Rickerts, V., Bargon, J., & Just‐Nübling, G. (2003) · Mycoses · doi:10.1046/j.1439-0507.2003.00830.x · Cited by 183
Mortensen, K. L., Jensen, R. H., Johansen, H. K., Skov, M., Pressler, T., Howard, S. J., Leatherbarrow, H., Mellado, E., & Arendrup, M. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00213-11 · Cited by 180
Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans
McAlester, G., O'Gara, F., & Morrissey, J. P. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47705-0 · Cited by 164
Willger, S. D., Grim, S. L., Dolben, E. L., Shipunova, A., Hampton, T. H., Morrison, H. G., Filkins, L. M., O‘Toole, G. A., Moulton, L. A., Ashare, A., et al. (2014) · Microbiome · doi:10.1186/2049-2618-2-40 · Cited by 156
“[15] found between 10(4) and 10(7) colony forming units per gram of sputum of Candida using culture methods.”
BackgroundMethodMorales, D. K., Jacobs, N. J., Rajamani, S., Krishnamurthy, M., Cubillos‐Ruiz, J. R., & Hogan, D. A. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07414.x · Cited by 154
“, 2009), two species commonly found together in mixed species biofilm-related infections (Hughes and Kim, 1973; Bauernfeind et al., 1987; Gupta et al., 2005; Chotirmall et al., 2010), has provided insight into the many different types of interactions occurring between species coexisting in close proximity.”
BackgroundLopez-Medina, E., Fan, D., Coughlin, L. A., Ho, E. X., Lamont, I. L., Reimmann, C., Hooper, L. V., & Koh, A. Y. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005129 · Cited by 143
“albicans [1,3,12,13], the impact on bacterial and/or fungal pathogenesis is still unclear [14,15].”
BackgroundChronic Inflammation in the Cystic Fibrosis Lung: Alterations in Inter- and Intracellular Signaling
Nichols, D. P., Chmiel, J. F., & Berger, M. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-8039-9 · Cited by 160
Xanthomonas maltophilia: An Emerging Nosocomial Pathogen
MARSHALL, W. F., Keating, M. R., Anhalt, J. P., & Steckelberg, J. M. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)64979-9 · Cited by 139
Trejo-Hernández, A., Andrade-Domínguez, A., Hernández, M., & Encarnación, S. (2014) · The ISME Journal · doi:10.1038/ismej.2014.53 · Cited by 135
“Pseudomonas and Candida are organisms that are commonly isolated from the sputum of cystic fibrosis patients (Hughes and Kim, 1973; Bauernfeind et al., 1987; Bakare et al., 2003).”
BackgroundHall, R. A., Turner, K. J., Chaloupka, J., Cottier, F., De Sordi, L., Sanglard, D., Levin, L. R., Buck, J., & Mühlschlegel, F. A. (2011) · Eukaryotic Cell · doi:10.1128/ec.05060-11 · Cited by 131
“cenocepacia (3, 6, 19, 44), both of which produce QSMs with activity against C.”
BackgroundPulmonary Aspergillosis in Cystic Fibrosis Lung Transplant Recipients
Nunley, D. R., Ohori, N. P., Grgurich, W. F., Iacono, A. T., Williams, P. A., Keenan, R. J., & Dauber, J. H. (1998) · CHEST Journal · doi:10.1378/chest.114.5.1321 · Cited by 128
Iron at the Centre of Candida albicans Interactions
Fourie, R., Kuloyo, O. O., Mochochoko, B. M., Albertyn, J., & Pohl, C. H. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00185 · Cited by 118
“albicans from patients’ lungs with cystic fibrosis (CF) as well as Streptococci (Bauernfeind et al., 1987; Friedman et al., 2006; Chotirmall et al., 2010).”
BackgroundHogan, D. A., Willger, S. D., Dolben, E. L., Hampton, T. H., Stanton, B. A., Morrison, H. G., Sogin, M. L., Czum, J., & Ashare, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149998 · Cited by 118
“in the lung, the most commonly detected species are Candida albicans, Candida parapsilosis, and Candida dubliniensis [18,33,60,61].”
BackgroundMetabolic Heterogeneity and Cross-Feeding in Bacterial Multicellular Systems
Evans, C. R., Kempes, C. P., Price‐Whelan, A., & Dietrich, L. E. P. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.03.008 · Cited by 124
“aeruginosa is one of the major species represented in the CF lung, which can contain bacterial loads on the order of 108 cells/gram of sputum [77].”
BackgroundMechanisms and markers of airway inflammation in cystic fibrosis: Fig. 1.—
Rose, V. D. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00229202 · Cited by 114
Fungi in the cystic fibrosis lung: Bystanders or pathogens?
Chotirmall, S. H., & McElvaney, N. G. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.03.001 · Cited by 125
“Differences include incubation temperatures, culture duration, culture number and media choice (Bakare et al., 2003; Bauernfeind et al., 1987; Paugam et al., 2010; Valenza et al., 2008) however in addition to sputum alone, specimen source also has influence.”
BackgroundIdentification and Detection of Stenotrophomonas maltophilia by rRNA-Directed PCR
Whitby, P. W., Carter, K. B., Burns, J. L., Royall, J. A., LiPuma, J. J., & Stull, T. L. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.12.4305-4309.2000 · Cited by 110
Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function?
de Vrankrijker, A. M. M., van der Ent, C. K., van Berkhout, F. T., Stellato, R. K., Willems, R. J. L., Bonten, M. J. M., & Wolfs, T. F. W. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03429.x · Cited by 120
“Reported prevalence rates of colonization in patients with CF vary, ranging from 6% to 58% [2–11].”
BackgroundHuang, Y. J., & Lynch, S. V. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.76 · Cited by 100
Liu, J. C., Modha, D. E., & Gaillard, E. A. (2013) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.02.003 · Cited by 89
“from CF respiratory specimens varies widely from 6 to 58% in the reported literature [3,5,9–18] and this is true for both, adult and paediatric patients, and across different geographical areas of the UK, Europe and North America.”
BackgroundIs primary prevention of asthma possible?
Becker, A. B. (2000) · Pediatric Pulmonology · doi:10.1002/1099-0496(200007)30:1<16::aid-ppul4>3.0.co;2-h · Cited by 25
Ulrich, M., Herbert, S., Berger, J., Bellon, G., Louis, D., Münker, G., & Döring, G. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.1.3137 · Cited by 81
Antibiotic Therapy for Chronic Infection of Pseudomonas in the Lung
Høiby, N. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.000245 · Cited by 81
Alipour, M., Suntres, Z. E., Lafrenie, R. M., & Omri, A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq036 · Cited by 85
Umetsu, D. T. (1998) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199805)25:5<352::aid-ppul12>3.0.co;2-3 · Cited by 172
Binding of staphylococci to mucus in vivo and in vitro
Sanford, B. A., Thomas, V. L., & Ramsay, M. A. (1989) · Infection and Immunity · doi:10.1128/iai.57.12.3735-3742.1989 · Cited by 74
Mixed bacterial-fungal infections in the CF respiratory tract
Leclair, L. W., & Hogan, D. A. (2010) · Medical Mycology · doi:10.3109/13693786.2010.521522 · Cited by 72
van Belkum, A., Renders, N. H. M., Smith, S., Overbeek, S. E., & Verbrugh, H. A. (2000) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(99)00161-3 · Cited by 66
Verweij, P. E., Meis, J. F. G. M., Sarfati, J., Hoogkamp-Korstanje, J. A. A., Latgé, J., & Melchers, W. J. G. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.10.2595-2597.1996 · Cited by 65
Candida species in cystic fibrosis: A road less travelled
Chotirmall, S. H., Greene, C. M., & McElvaney, N. G. (2010) · Medical Mycology · doi:10.3109/13693786.2010.503320 · Cited by 61
del Campo, R., Morosini, M.-I., de la Pedrosa, E. G.-G., Fenoll, A., Muñoz‐Almagro, C., Máiz, L., Baquero, F., Cantón, R., & the Spanish Pneumococcal Infection Study Network (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.5.2207-2214.2005 · Cited by 61
“Although this organism can be recovered from respiratory samples from CF patients in early stages of the disease (5, 16), there is no clear relationship with severe bacterial complications or with pulmonary deterioration (14).”
BackgroundKarpati, F., Malmborg, A. S., Alfredsson, H., Hjelte, L., & Strandvik, B. (1994) · Infection · doi:10.1007/bf01739911 · Cited by 60
“There are only a few studies available reporting the prevalence [8-11] or the antibiotic susceptibility of this organism in CF patients [8-10,12].”
BackgroundResultPersistence of Candida species in the respiratory tract of cystic fibrosis patients
Muthig, M., Hebestreit, A., Ziegler, U., Seidler, M., & Müller, F.-M. C. (2010) · Medical Mycology · doi:10.3109/13693780802716532 · Cited by 55
Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All
Kean, R., Delaney, C., Rajendran, R., Sherry, L., Metcalfe, R., Thomas, R., McLean, W., Williams, C., & Ramage, G. (2018) · Journal of Fungi · doi:10.3390/jof4010012 · Cited by 55
“albicans Pseudomonas aeruginosa [32,33] Gastrointestinal tract C.”
Pathogenesis of Fungal Infections in Cystic Fibrosis
Williams, C., Ranjendran, R., & Ramage, G. (2016) · Current Fungal Infection Reports · doi:10.1007/s12281-016-0268-z · Cited by 61
“fumigatus has a prevalence rate of between 10 and 57% [4, 62], though other Aspergillus species have been isolated from the lungs including A.”
BackgroundRiethmueller, J., Junge, S., Schroeter, T. W., Kuemmerer, K., Franke, P., Ballmann, M., Claaß, A., Broemme, S., Jeschke, R., Hebestreit, A., et al. (2009) · Infection · doi:10.1007/s15010-009-8116-5 · Cited by 48
Aspergilluscolonization and antifungal immunity in cystic fibrosis patients
Warris, A., Bercusson, A., & Armstrong-James, D. P. H. (2018) · Medical Mycology · doi:10.1093/mmy/myy074 · Cited by 54
Dimer, F. A., Carvalho‐Wodarz, C. D. S., Goes, A., Cirnski, K., Herrmann, J. E., Schmitt, V., Pätzold, L., Abed, N., Rossi, C. D., Bischoff, M., et al. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102125 · Cited by 55
Dynamic interaction between airway epithelial cells andStaphylococcus aureus
da Silva, M. C. A., Zahm, J., Gras, D., Bajolet, O., Abély, M., Hinnrasky, J., Milliot, M., de Assis, M. C., Hologne, C., Bonnet, N., et al. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00256.2003 · Cited by 44
“aureus is also frequently involved in early infectious airway disease in cystic fibrosis (CF) patients (2, 3).”
BackgroundAbdel-Rhman, S. H., El-Mahdy, A. M., & El‐Mowafy, M. (2015) · BioMed Research International · doi:10.1155/2015/456463 · Cited by 47
Candida albicans interaction with Gram-positive bacteria within interkingdom biofilms
Bernard, C., Girardot, M., & Imbert, C. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.100909 · Cited by 54
Candida albicans: Molecular interactions with Pseudomonas aeruginosa and Staphylococcus aureus
Lindsay, A. K., & Hogan, D. A. (2014) · Fungal Biology Reviews · doi:10.1016/j.fbr.2014.10.002 · Cited by 52
Stewart, L., Griffiss, J. M., Jarvis, G. A., & Way, L. W. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0168-1 · Cited by 40
Doing, G., Koeppen, K., Occhipinti, P., Harty, C. E., & Hogan, D. A. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008783 · Cited by 35
Latzin, P., Fehling, M., Bauernfeind, A., Reinhardt, D., Kappler, M., & Griese, M. (2007) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2007.07.001 · Cited by 37
Self-citationCamarillo-Márquez, O., Córdova-Alcántara, I. M., Hernández, G., García‐Pérez, B. E., Martínez-Rivera, M. Á., & Rodríguez-Tovar, A. V. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02031 · Cited by 41
“aureus can cause super-infections via the formation of mixed biofilms, for example, in the lungs of patients with cystic fibrosis (Bauernfeind et al., 1987).”
BackgroundStenotrophomonas (Xanthomonas) maltophilia: A Multidrug‐Resistant Nosocomial Pathogen
Penzak, S. R., & Abate, B. J. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03712.x · Cited by 40
Serologic response to candida albicans and aspergillus fumigatus in cystic fibrosis
Przyklenk, B., Bauernfeind, A., Hörl, G., & Emminger, G. (1987) · Infection · doi:10.1007/bf01644143 · Cited by 32
Self-citationCoorens, M., Banaschewski, B. J. H., Baer, B., Yamashita, C. M., van Dijk, A. I. J. M., Haagsman, H. P., Veldhuizen, R. A. W., & Veldhuizen, E. J. A. (2017) · Infection and Immunity · doi:10.1128/iai.00546-17 · Cited by 33
Frequency of fungi in respiratory samples from Turkish cystic fibrosis patients
Güngör, Ö., Tamay, Z., Güler, N., & Erturan, Z. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02221.x · Cited by 33
Schwarz, C., Vandeputte, P., Rougeron, A., Giraud, S., de Bernonville, T. D., Duvaux, L., Gastebois, A., Alastruey‐Izquierdo, A., Martín-Gómez, M. T., Martín‐Mazuelos, E., et al. (2017) · Medical Mycology · doi:10.1093/mmy/myx106 · Cited by 39
Riethmueller, J., Ballmann, M., Schroeter, T. W., Franke, P., Butler, R., Claaß, A., Junge, S., Doering, G., & Stern, M. (2009) · Infection · doi:10.1007/s15010-009-8117-4 · Cited by 31
“PA counts in sputum and pseudomonas antibodies in serum were determined as previously described [17–19].”
MethodEpidemiological typing of Stenotrophomonas maltophilia
Marty, N. (1997) · Journal of Hospital Infection · doi:10.1016/s0195-6701(97)90052-9 · Cited by 29
Potts, S. B., Roggli, V. L., & Spock, A. (1995) · Pediatric Pathology & Laboratory Medicine · doi:10.3109/15513819509027007 · Cited by 28
Calcium- and Mucin-Binding Proteins of Staphylococci
Thomas, V. L., Sanford, B. A., & Ramsay, M. A. (1993) · Journal of General Microbiology · doi:10.1099/00221287-139-3-623 · Cited by 28
Goering, R. V., Bauernfeind, A., Przyklenk, B., & Lenz, W. (1990) · Infection · doi:10.1007/bf01644187 · Cited by 27
“Of the variety of microorganisms found in the sputum of patients with cystic fibrosis Staphylococcus aureus is the most commonly isolated gram-positive pathogen [ 1 , 2, 4]. While various studies have addressed the isolation and antimicrobial susceptibility of S. aureus from cystic fibrosis patients [2, 5-7], the epid…”
BackgroundSelf-citationBao, H., Qiao, Y., Liu, D., Chen, J., Wu, X., Hu, X., Ma, X., & Wu, D. (2019) · Infection · doi:10.1007/s15010-019-01369-4 · Cited by 30
Epidemiology ofStaphylococcus aureusin patients with cystic fibrosis
Branger, C., Fournier, J. M., Loulergue, J., Bouvet, A., Goullet, P., Boutonnier, A., de Gialluly, C., Couetdic, G., Chomarat, M., Jaffar‐Bandjee, M., et al. (1994) · Epidemiology and Infection · doi:10.1017/s0950268800051190 · Cited by 26
Aspergillus Biofilms in Human Disease
Williams, C., Rajendran, R., & Ramage, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_4 · Cited by 27
Lahiri, T., & Waltz, D. A. (2001) · PEDIATRICS · doi:10.1542/peds.108.4.e62 · Cited by 25
Fragaki, K., Kileztky, C., Trentesaux, C., Zahm, J., Bajolet, O., Johnson, M., & Puchelle, É. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00488.2005 · Cited by 21
Home and Hospital Antibiotic Treatment Prove Similarly Effective in Cystic Fibrosis
Riethmueller, J., Busch, A., Damm, V., Ziebach, R., & Stern, M. (2002) · Infection · doi:10.1007/s15010-002-2095-0 · Cited by 21
An overview on impact and application of microorganisms on human health, medicine and environment
Maraz, K. M., & Khan, R. A. (2021) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2021.16.1.0200 · Cited by 23
Máiz, L., Cuevas, M., Lamas, A., Sousa, A., Quirce, S., & Suárez, L. (2008) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(08)60029-4 · Cited by 17
Co-occurence of filamentation defects and impaired biofilms inCandida albicansprotein kinase mutants
Konstantinidou, N., & Morrissey, J. P. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov092 · Cited by 20
Hsieh, Y.-Y. P., Sun, W., Young, J. M., Cheung, R., Hogan, D. A., Dandekar, A. A., & Malik, H. S. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002694 · Cited by 22
Máiz, L., Cuevas, M., Lamas, A., Sousa, A., Quirce, S., & Suárez, L. (2008) · Archivos de Bronconeumología · doi:10.1157/13116602 · Cited by 16
Truncation of type IV pilin induces mucoidy in P seudomonas aeruginosa strain PAO579
Withers, T. R., Damron, F. H., Yin, Y., & Yu, H. D. (2013) · MicrobiologyOpen · doi:10.1002/mbo3.86 · Cited by 15
“459 environment for the adherence and cultivation of microbial pathogens (Bauernfeind et al. 1987; Saiman et al. 1992).”
BackgroundMethodInfluentialCandida albicans chronic colonisation in cystic fibrosis may be associated with inhaled antibiotics
Noni, M., Katelari, A., Kaditis, A. G., Theochari, I., Lympari, I., Alexandrou-Athanassoulis, H., Doudounakis, S. E., & Dimοpoulos, G. (2015) · Mycoses · doi:10.1111/myc.12338 · Cited by 14
Remodeling of O Antigen in Mucoid Pseudomonas aeruginosa via Transcriptional Repression of wzz2
Cross, A. R., & Goldberg, J. B. (2019) · mBio · doi:10.1128/mbio.02914-18 · Cited by 14
Güngör, Ö., Sampaio‐Maia, B., Amorim, A., Araújo, R., & Erturan, Z. (2018) · Mycopathologia · doi:10.1007/s11046-018-0297-y · Cited by 15
Implications of Interspecies Signaling for Virulence of Bacterial and Fungal Pathogens
Holcombe, L. J., O’Gara, F., & Morrissey, J. P. (2011) · Future Microbiology · doi:10.2217/fmb.11.60 · Cited by 14
Cation complexation by mucoid Pseudomonas aeruginosa extracellular polysaccharide
Hills, O. J., Smith, J., Scott, A. J., DeVine, D., & Chappell, H. F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257026 · Cited by 13
Siefferman, C. M., Regelmann, W. E., & Gray, B. H. (1991) · Infection and Immunity · doi:10.1128/iai.59.6.2152-2157.1991 · Cited by 13
Bauernfeind, A., Emminger, G., Hörl, G., Lorbeer, B., Przyklenk, B., & Weisslein-Pfister, C. (1987) · Infection · doi:10.1007/bf01647240 · Cited by 12
“Although strains of various species were identified (1) P.”
BackgroundSelf-citationViral infections of the respiratory tract in patients with cystic fibrosis
Przyklenk, B., Bauernfeind, A., Bertele, R. M., Deinhardt, F., & Harms, K. (1988) · Serodiagnosis and Immunotherapy in Infectious Disease · doi:10.1016/0888-0786(88)90057-1 · Cited by 11
Self-citationThe Yin and Yang of Phenazine Physiology
Grahl, N., Kern, S. E., Newman, D. K., & Hogan, D. A. (2013) · Springer eBooks · doi:10.1007/978-3-642-40573-0_3 · Cited by 15
Bacteriological effects of anti-pseudomonas aeruginosa chemotherapy in cystic fibrosis
Bauernfeind, A., Emminger, G., Hörl, G., Ott, S., Przyklenk, B., & Weisslein-Pfister, C. (1987) · Infection · doi:10.1007/bf01647753 · Cited by 11
Self-citation
Metadata
- Authors
- Bauernfeind, A., Hörl, G., Jungwirth, R., Petermüller, C., Przyklenk, B., Weisslein-Pfister, C., Bertele, R. M., & Harms, K.
- Affiliations
- Max-von-Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie (DE)
- Ludwig-Maximilians-Universität München (DE)
- ORCID
- Hörl, G.
- Venue
- Infection
- Published
- 1987-07
- Volume
- 15
- Issue
- 4
- Pages
- 270-277
- ISSN
- 0300-8126 (ISSN-L)
- 1439-0973
- OpenAlex
- W85901280
- Cited by
- 150
- References
- 31
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 6 · 2017: 7 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 6 · 2012: 2
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Infection (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- cystic fibrosis, sputum microbiology, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Candida albicans, Staphylococcus aureus, Staphylococcus epidermidis, Haemophilus influenzae, Aspergillus fumigatus, bacterial persistence, bacterial co-infection
- MeSH terms
- Adolescent, Adult, Bacteria, Child, Child, Preschool, Cystic Fibrosis, Mitosporic Fungi, Female, Haemophilus influenzae, Humans, Male, Pseudomonas, Pseudomonas aeruginosa, Sputum, Staphylococcus, Streptococcus pneumoniae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.